Stand out for this role — generate a tailored resume and cover letter in about a minute.
Engitix Therapeutics, a London-based biotechnology company, seeks a detail-driven Biospecimens Coordinator to own the daily operations of our human tissue repository. You will manage the full lifecycle of biospecimens, from procurement to distribution, ensuring traceability and data integrity within a fast-paced R&D environment.
Ideal candidates have 2+ years in tissue banking or sample management, experience with HTA regulations, and proficiency with LIMS.
Engitix Therapeutics is a London-based biotechnology company unlocking the extracellular matrix (ECM) as a source of novel therapeutic targets for fibrosis and cancer. Through our unique understanding of the ECM, world-class technology, and distinctive approach, we're generating insights that power the development of new, advanced therapeutics. At the heart of this work is our biological samples resource, the foundation that lets us validate these insights into organ and disease biology and turn cutting-edge science into real progress toward meaningful treatment options. We're looking for a detail-driven Biospecimens Coordinator to take ownership of the daily operations of our human tissue repository. You'll lead the full lifecycle of our human biological samples, from acquisition, storage, annotation, and quality control through to distribution, ensuring the integrity of a resource that directly underpins our research and development programmes.
Engitix is a growing biotech company based in White City Place, West London. We are dedicated to developing better therapies for advanced fibrosis and solid tumours by leveraging our pioneering extracellular matrix (ECM) platform. Our platform allows the synthesis of realistic in vitro 3D models that serve as tools to transform our ability to identify new targets and biomarkers, determine mechanisms of action and more accurately predict the efficacy of therapeutic candidates. Join us today in our mission to create a healthier future for patients with life-threatening diseases such as fibrosis and cancer.